Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

FX CorAL 40 (F00009214); FX CorAL 50 (F00009215)

K-Number: K242053 · 2025-03-21

Decision Date2025-03-21
Product CodeKDI
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

FX CorAL 40 (F00009214); FX CorAL 50 (F00009215) is a medical device manufactured by Fresenius Medical Care Renal Therapies Group, LLC. It received FDA 510(k) clearance on 2025-03-21 under approval number K242053. The device is classified under product code KDI. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the FX CorAL 40 (F00009214); FX CorAL 50 (F00009215)?

FX CorAL 40 (F00009214); FX CorAL 50 (F00009215) is a medical device that received FDA 510(k) clearance on 2025-03-21. It is manufactured by Fresenius Medical Care Renal Therapies Group, LLC. The 510(k) number is K242053.

When was FX CorAL 40 (F00009214); FX CorAL 50 (F00009215) approved by the FDA?

FX CorAL 40 (F00009214); FX CorAL 50 (F00009215) received FDA 510(k) clearance on 2025-03-21, under approval number K242053.

What company makes FX CorAL 40 (F00009214); FX CorAL 50 (F00009215)?

FX CorAL 40 (F00009214); FX CorAL 50 (F00009215) is manufactured by Fresenius Medical Care Renal Therapies Group, LLC.

What is the FDA product code for FX CorAL 40 (F00009214); FX CorAL 50 (F00009215)?

The FDA product code for FX CorAL 40 (F00009214); FX CorAL 50 (F00009215) is KDI.

Other Devices by Fresenius Medical Care Renal Therapies Group, LLC

View all 47 devices →

Related Devices (Code: KDI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.